Jahrgang 2013
Böhm M, Borer J, Ford I, Gonzalez-Juanatey JR, Komajda M, Lopez-Sendon J, Reil JC, Swedberg K, Tavazzi L (2013)
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT-study.
Clin Res Cardiol 102: 11-22Senni M, Parrella P, De Maria R, Cottini C, Böhm M, Ponikowski P, Filippatos G, Tribouilloy C, Di Lenarda A, Oliva F, Pulignano G, Cicoira M, Nodari S, Porcu M, Gioffi G, Gabrielli D, Parodi O, Ferrazzi P, Gavazzi A (2013)
Predicting heart failure outcome from cardiac and comorbid conditions: The 3C-HF score.
Int J Cardiol 163: 206-211Linz D, Mahfoud F, Schotten U, Ukena C, Hohl M, Neuberger HR, Wirth K, Böhm M (2013)
Renal Sympathetic Denervation Provides Ventricular Rate Control But Does Not Prevent Atrial Electrical Remodeling During Atrial Fibrillation.
Hypertension 61: 225-231Komajda M, Böhm M, Borer J, Ford I, Krum H, Tase A, Tavazzi L, Swedberg K (2013)
Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine’s effects in patients with chronic heart failure.
Eur J Heart Fail 15: 79-84Hohl M, Wagner M, Reil JC, Müller SA, Tauchnitz M, Zimmer AM, Lehmann LH, Thiel G, Böhm M, Backs J, Maack C (2013)
HDAC4 controls histone methylation in response to elevated cardiac load.
J Clin Invest 123: 1359-1370Gheorghiade M, Böhm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F, Solomon SD, Baschiera F, Botha J, Hua TA, Gimpelewicz CR, Jaumont X, Lesogor A, Maggioni AP for the ASTRONAUT Investigators and Coordinators (2013)
Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure - The ASTRONAUT Randomized Trial.
JAMA 309: 1125-1135Abrahamsson P, Swedberg K, Borer JS, Böhm M, Kober L, Komajda M, Lloyd SM, Metra M, Tavazzi L, Ford I (2013)
Risk following hospitalization in stable chronic systolic heart failure.
Eur J Heart Fail 15: 885-891Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD (2013)
Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
Int J Cardiol 168: 2214-2220Mann JFE, Anderson C, Gao P, Gerstein HC, Böhm M, Rydén L, Sleight P, Koon KT, Yusuf S on behalf of the ONTARGET investigators (2013)
Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial.
J Hypertens 31: 414-421Reil JC, Robertson M, Ford I, Borer J, Komajda M, Swedberg K, Tavazzi L, Böhm M (2013)
Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failure.
Eur J Heart Fail 15: 1044-1052Scheller B, Fischer D, Clever YP, Kleber FX, Speck U, Böhm M, Cremers B (2013)
Treatment of a coronary bifurcation lesion with drug-coated balloons: lumen enlargement and plaque modification after 6 months
Clin Res Cardiol 102: 469-472Hering D, Lambert EA, Marusic P, Ika-Sari C, Walton AS, Krum H, Sobotka PA, Mahfoud F, Böhm M, Lambert GW, Esler MD, Schlaich MP (2013)
Renal nerve ablation reduces augmentation index in patients with resistant hypertension.
J Hypertension 31: 1893-1900Al Bannay R, Böhm M, Husain A (2013)
Heart rate differentiates urgency and emergency in hypertensive crisis.
Clin Res Cardiol 102: 593-598Böhm M, Schumacher H, Laufs U, Sleight P, Schmieder R, Unger T, Teo K, Yusuf S (2013)
Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease.
Am Heart J 166: 306-314Kazakov A, Hall R, Jagoda P, Bachelier K, Müller-Best P, Semenov A, Lammert F, Böhm M, Laufs U (2013)
Inhibition of endothelial nitric oxide synthase induces and enhances myocardial fibrosis.
Cardiovasc Res 100: 211-221Linz D, Wirth K, Ukena C, Mahfoud F, Pöss J, Linz B, Böhm M, Neuberger HR (2013)
Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs.
Heart Rhythm 10: 1525-1530Kratz MT, Schumacher H, Sliwa K, Schmieder R, Pöss J, Mahfoud F, Unger T, Lonn E, Koon T, Mancia G, Sleight P, Yusuf S, Böhm M (2013)
Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients.
Eur J Prev Cardiol 21: 272-280de Waha S, Eitel I, Desch S, Scheller B, Böhm M, Lauer B, Gawaz M, Geisler T, Gunkel O, Bruch L, Klein N, Pfeiffer D, Schuler G, Zeymer U, Thiele H (2013)
Thrombus Aspiration in ThrOmbus containing culpRiT lesions in Non-ST-Elevation Myocardial Infarction (TATORT-NSTEMI): study protocol for a randomized controlled trial.
Trials 14: 110Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M (2013)
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
Circulation 128: 132-140Hering D, Lambert EA, Marusic P, Ika-Sari C, Walton AS, Krum H, Sobotka PA, Mahfoud F, Böhm M, Lambert GW, Esler MD, Schlaich MP (2013)
Renal nerve ablation reduces augmentation index in patients with resistant hypertension.
J Hypertens 31: 1893-1900Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, Böhm M (2013)
Effects of Electrical Stimulation of Carotid Baroreflex and Renal Denervation on Atrial Electrophysiology.
J Cardiovasc Electrophysiol 24: 1028-1033Pöss J, Lorenz D, Werner C, Pavlikova V, Gensch C, Speer T, Alessandrini F, Berezowski V, Kuntz M, Mempel M, Endres M, Böhm M, Laufs U (2013)
Diesel Exhaust Particles Impair Endothelial Progenitor Cells, Compromise Endothelial Integrity, Reduce Neoangiogenesis, and Increase Atherogenesis in Mice.
Cardiovasc Toxicol 13: 290-300Fox K, Komajda M, Ford I, Robertson M, Böhm M, Borer JS, Steg PG, Tavazzi L, Tendera M, Ferrari R, Swedberg K (2013)
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials.
Eur Heart J 34: 2263-2270Scheller B, Fischer D, Clever YP, Kleber FX, Speck U, Böhm M, Cremers B (2013)
Treatment of a coronary bifurcation lesion with drug-coated balloons: lumen enlargement and plaque modification after 6 months.
Clin Res Cardiol 102: 469-472Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, Löffler M, Düngen HD, Tschöpe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Pieske B; Aldo-DHF Investigators (2013)
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
JAMA 309: 781-791Link A, Pöss J, Rbah R, Barth C, Feth L, Selejan S, Böhm M (2013)
Circulating angiopoietins and cardiovascular mortality in cardiogenic shock.
Eur Heart J 34: 1651-1662Mahfoud F, Böhm M, Rump LC, Vonend O, Schmieder RE, Kintscher U (2013)
Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series.
Hypertension 61: e17Böhm M, Schumacher H, Laufs U, Sleight P, Schmieder R, Unger T, Teo K, Yusuf S (2013)
Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease.
Am Heart J 166: 306-314Böhm M, Mahfoud F, Ukena C, Bauer A, Fleck E, Hoppe UC, Kintscher U, Narkiewicz K, Negoita M, Ruilope L, Rump C, Schlaich M, Schmieder R, Sievert H, Weil J, Williams B, Zeymer U, Mancia G (2013)
Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry.
Euro Intervention 9: 484-492Pöss J, Mahfoud F, Seiler S, Heine GH, Fliser D, Böhm M, Link A (2013)
FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock.
Eur Heart J Acute Cardiovasc Care 2: 211-218Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Rainer Hambrecht, Lauer B, Böhm M, Ebelt H, Schneider S, Werdan K, Schuler G, on behalf of the Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators (2013)
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.
Lancet 382: 1638-1645Beckmann A, Hamm C, Figulla HR, Cremer J, H Kuck K, Lange R, Zahn R, Sack S, Schuler GC, Walther T, Beyersdorf F, Böhm M, Heusch G, Funkat AK, Meinertz T, Neumann T, Papoutsis K, Schneider S, Welz A, Mohr FW for the GARY Executive Board (2013)
The German Aortic Valve Registry (GARY): A Nationwide Registry for Patients Undergoing Invasive Therapy for Severe Aortic Valve Stenosis.
Thorac Cardiovasc Surg 60: 319-325Reil JC, Hohl M, Reil GH, Granzier HL, Kratz MT, Kazakov A, Fries P, Müller A, Lenski M, Custodis F, Gräber S, Fröhlig G, Steendijk P, Neuberger HR, Böhm M (2013)
Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction.
Eur Heart J 34: 2839-2849Linz D, Hohl M, Nickel A, Mahfoud F, Wagner M, Ewen S, Schotten U, Maack C, Wirth K, Böhm M (2013)
Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea.
Hypertension 62: 767-774Erdine S, Redon J, Böhm M, Ferri C, Kolloch R, Kreutz R, Laurent S, Persu A, Schmieder R on behalf of the SHARE steering committee (2013)
Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and research Europe-wide (SHARE) survey.
Eur J Prev Cardiol 20: 786-792Reil JC, Tardif JC, Ford I, Lloyd S, O’Meara E, Komajda M, Borer JS, Tavazzi L, Swedberg K, Böhm M (2013)
Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients.
J Am Coll Cardiol 62: 1977-1985Tavazzi L, Swedberg K, Komajda M, Böhm M, Borer JS, Lainsack M, Ford I on behalf of the SHIFT Investigators (2013)
Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study.
Eur J Heart Fail 15: 1296-1303Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder R (2013)
Renal denervation in moderate treatment-resistant hypertension.
J Am Coll Cardiol 62: 1880-1886Lenski D, Kindermann I, Lenski M, Ukena C, Bunz M, Mahfoud F, Böhm M (2013)
Anxiety, depression, quality of life and stress in patients with resistant hypertension before and after catheter-based renal sympathetic denervation.
Euro Intervention 9: 700-708Tavazzi L, Swedberg K, Komajda M, Böhm M, Borer JS, Lainscak M, Robertson M, Ford I, SHIFT Investigators (2013)
Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.
Int J Cardiol 170: 182-188Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C, Linz D, Laufs U, Böhm M (2013)
Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
Int J Cardiol 169: 418-424
